|1.||Mellgren, Gunnar: 3 articles (01/2016 - 04/2010)|
|2.||Sagen, Jørn V: 2 articles (01/2016 - 01/2013)|
|3.||O'Malley, Bert W: 2 articles (03/2015 - 01/2012)|
|4.||Stashi, Erin: 2 articles (03/2015 - 01/2012)|
|5.||Ittmann, Michael M: 2 articles (03/2015 - 11/2006)|
|6.||Zhang, Hua: 2 articles (01/2009 - 08/2004)|
|7.||Shang, Yongfeng: 2 articles (01/2009 - 08/2004)|
|8.||Bjune, Jan-Inge: 1 article (01/2016)|
|9.||Bjørkhaug, Lise: 1 article (01/2016)|
|10.||Madsen, Andre: 1 article (01/2016)|
|1.||Breast Neoplasms (Breast Cancer)
01/01/2009 - "Interestingly, GAS interacts only with SRC1, and not with glucocorticoid receptor interacting protein 1 (GRIP1) or amplified in breast cancer 1 (AIB1), the other two members of the SRC family. "
01/01/2013 - "Downregulation of steroid receptor coactivator-2 modulates estrogen-responsive genes and stimulates proliferation of mcf-7 breast cancer cells."
01/01/2003 - "Various kinds of cofactors, such as steroid receptor coactivator-1 (SRC-1), transcription intermediary factor 2 (TIF2), and amplified in breast cancer 1 (AIB1), have also been reported. "
11/30/2001 - "To explain how these differences in transactivation might occur, we have examined the interaction of ERbeta with these EREs and monitored recruitment of the coactivators amplified in breast cancer (AIB1) and transcription intermediary factor 2 (TIF2). "
06/01/2009 - "Estrogen receptor coregulators, amplified in breast cancer 1 (AIB1) and transcription intermediary factor 2 (TIF2), have been well-characterized, but their expression in colorectal carcinomas has not been investigated. "
|2.||Prostatic Neoplasms (Prostate Cancer)
11/01/2006 - "We sought to assess the consequences of reducing expression of the transcription intermediary factor 2 (TIF2) coactivator on prostate cancer cell growth and AR action in cell lines to examine TIF2 expression in prostate cancer and to correlate expression with clinical outcome. "
02/20/2004 - "In this report, we show that epidermal growth factor (EGF) increases androgen-dependent AR transactivation in the recurrent prostate cancer cell line CWR-R1 through a mechanism that involves a post-transcriptional increase in the p160 coactivator transcriptional intermediary factor 2/glucocorticoid receptor interacting protein 1 (TIF2/GRIP1). "
11/01/2006 - "Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer."
03/02/2015 - "Here, we determined that upregulation of the oncogenic transcriptional coregulator steroid receptor coactivator 2 (SRC-2), also known as NCOA2, drives glutamine-dependent de novo lipogenesis, which supports tumor cell survival and eventual metastasis. "
05/01/2009 - "Amplified in breast cancer (AIB1 or SRC-3) is an estrogen receptor coregulatory protein that together with other co-activators like transcription intermediary factor 2 (TIF2) and nuclear receptor co-repressor (NCoR), is implicated in estrogen signaling pathway and estrogen regulated tumor progression. "
|5.||Colorectal Neoplasms (Colorectal Cancer)
|1.||Steroid Receptors (Steroid Receptor)
|3.||Nuclear Receptor Coactivator 1
|5.||Transcription Factors (Transcription Factor)
|7.||Estrogen Receptor beta
|8.||Carrier Proteins (Binding Protein)
|10.||Histone Acetyltransferases (Histone Acetyltransferase)